In the last trading session, 6.45 million shares of the Hepion Pharmaceuticals Inc (NASDAQ:HEPA) were traded, and its beta was 1.59. Most recently the company’s
Hepion Pharmaceuticals Inc (NASDAQ:HEPA)’s traded shares stood at 5.12 million during the last session, with the company’s beta value hitting 1.59. At the close of
Hepion Pharmaceuticals Inc (NASDAQ:HEPA)’s traded shares stood at 4.36 million during the last session, with the company’s beta value hitting 1.59. At the close of
In the last trading session, 8.46 million Hepion Pharmaceuticals Inc (NASDAQ:HEPA) shares changed hands as the company’s beta touched 1.65. With the company’s per share
In the last trading session, 7.62 million Hepion Pharmaceuticals Inc (NASDAQ:HEPA) shares changed hands as the company’s beta touched 1.63. With the company’s per share
In last trading session, Hepion Pharmaceuticals Inc (NASDAQ:HEPA) saw 9.84 million shares changing hands with its beta currently measuring 1.65. Company’s recent per share price
In recent trading session, Hepion Pharmaceuticals Inc (NASDAQ:HEPA) saw 3.06 million shares changing hands at last check today with its beta currently measuring 1.65. Company’s
Hepion Pharmaceuticals Inc (NASDAQ:HEPA) has a beta value of 1.61 and has seen 26.85 million shares traded in the last trading session. The company, currently
Hepion Pharmaceuticals Inc (NASDAQ:HEPA) has a beta value of 1.61 and has seen 36.1 million shares traded in the last trading session. The company, currently
During the last session, Hepion Pharmaceuticals Inc (NASDAQ:HEPA)’s traded shares were 35.16 million, with the beta value of the company hitting 1.67. At the end
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
